Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Goshima

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Medical Virology|November 16, 2004
In vitro and in vivo analysis of human herpesvirus-6 U90 protein expressionN Nishimura, T Yoshikawa, T Ozaki, et al.
Acta Paediatrica Japonica : Overseas Edition|August 1, 1995
Relation between serum hepatitis C virus-RNA levels and efficacy of interferon-beta therapyY Minohara, T Kato, K Kanki, et al.
Cancer Gene Therapy|October 2, 2010
Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancerS Fujiwara, A Nawa, C Luo, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1995
[Familial clustering case of hepatitis delta]Y Minohara, T Kato, K Kanki, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1993
[Detection of antibody to varicella zoster virus by immune adherence hemagglutination]N Nakajima, Y Minohara, F Goshima, et al.
Archives of Virology|March 29, 2003
Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent miceH Takakuwa, F Goshima, N Nozawa, et al.
Cancer Gene Therapy|April 7, 2007
Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapyH Kasuya, Y Nishiyama, S Nomoto, et al.
Japanese Journal of Medical Science & Biology|April 1, 1997
A comparison of young and aged populations for the diphtheria and tetanus antitoxin titers in JapanM Takahashi, T Komiya, T Fukuda, et al.
Current Cancer Drug Targets|March 10, 2007
Clinical experiment of mutant herpes simplex virus HF10 therapy for cancerA Nakao, S Takeda, S Shimoyama, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1996
[A case of neonatal herpes infection which proved to be a mixed infection of herpes simplex virus type 1 and type 2]Y Minohara, T Kato, K Kanki, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medical Virology|November 16, 2004
In vitro and in vivo analysis of human herpesvirus-6 U90 protein expressionN Nishimura, T Yoshikawa, T Ozaki, et al.
Acta Paediatrica Japonica : Overseas Edition|August 1, 1995
Relation between serum hepatitis C virus-RNA levels and efficacy of interferon-beta therapyY Minohara, T Kato, K Kanki, et al.
Cancer Gene Therapy|October 2, 2010
Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancerS Fujiwara, A Nawa, C Luo, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1995
[Familial clustering case of hepatitis delta]Y Minohara, T Kato, K Kanki, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1993
[Detection of antibody to varicella zoster virus by immune adherence hemagglutination]N Nakajima, Y Minohara, F Goshima, et al.
Archives of Virology|March 29, 2003
Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent miceH Takakuwa, F Goshima, N Nozawa, et al.
Cancer Gene Therapy|April 7, 2007
Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapyH Kasuya, Y Nishiyama, S Nomoto, et al.
Japanese Journal of Medical Science & Biology|April 1, 1997
A comparison of young and aged populations for the diphtheria and tetanus antitoxin titers in JapanM Takahashi, T Komiya, T Fukuda, et al.
Current Cancer Drug Targets|March 10, 2007
Clinical experiment of mutant herpes simplex virus HF10 therapy for cancerA Nakao, S Takeda, S Shimoyama, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1996
[A case of neonatal herpes infection which proved to be a mixed infection of herpes simplex virus type 1 and type 2]Y Minohara, T Kato, K Kanki, et al.
Pageof 5